Kazia Therapeutics Ltd（KZIA）价格预测

$12.630

-1.046 (-8.28%)收盘时

价格预测

1-Day Price Prediction

-1.02%

1-Week Prediction

-19.77%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

KZIA 相似图表分析预测

Alphio's KZIA stock price prediction model matches the current Kazia Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.50 (-1.02%). The 1-week path is $10.13 (-19.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Kazia Therapeutics Ltd 股票吗？

Kazia Therapeutics Ltd is a good buy right now, trading at $13.58 with a forward P/E of 12.82, suggesting it is undervalued relative to future earnings. The recent announcement of a 100% clinical benefit rate in advanced triple-negative breast cancer patients highlights the potential of its lead asset, paxalisib, which could drive future revenue. However, the stock is currently facing a risk of dilution due to a recent public offering priced at $16.70, which may impact short-term investor sentiment.

KZIA 股价于 Tuesday 收于 $12.63，此前下跌 -8.28%

Kazia Therapeutics Ltd (KZIA) last closed at $12.63, losing -8.28%. These facts feed the 1-day and 1-week KZIA price prediction above.

预测驱动因素

Kazia Therapeutics Ltd（KZIA）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Negative

Bearish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 KZIA 最接近的股票，按相似度排序。

SCCO

80.71%

-34.00%

FCX

80.39%

-3.07%

KZIA 季节性分析

Historically the probability of a positive September return for KZIA is 2.38%. July offers the highest probability of a positive month at 66.67%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…